SCHEMBL6556578

SCHEMBL6556578

CCOc1cc(Cc2cnc(N)nc2N)cc(O)c1-c1ccc(C)c(N)c1

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHFR P00374 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6556613 0.93 DHFR (0.58) DHFR
SCHEMBL6556529 0.92 DHFR (0.53) DHFR
SCHEMBL6555407 0.88 DHFR (0.57) DHFR
SCHEMBL6555119 0.87 DHFR (0.53) DHFR
SCHEMBL6555386 0.87 DHFR (0.56) DHFR
SCHEMBL6555293 0.85 DHFR (0.60) DHFR
SCHEMBL6555486 0.85 DHFR (0.55) DHFR
SCHEMBL6555258 0.85 DHFR (0.54) DHFR
SCHEMBL6557483 0.84 DHFR (0.58) DHFR
SCHEMBL6555195 0.83 DHFR (0.63) DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1230224-B1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2004-12-29 EP disclosed
US-6821980-B1 Substituted 5-benzyl-2,4-diaminopyrimidines BASILEA PHARMACEUTICA AG (CH) 2004-11-23 US disclosed
EP-1230224-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES F. HOFFMANN-LA ROCHE AG (CH) 2002-08-14 EP disclosed
WO-2001032633-A1 SUBSTITUTED 5-BENZYL-2,4-DIAMINOPYRIMIDINES BASILEA PHARMACEUTICA AG (CH) 2001-05-10 WO disclosed